02/14/2024 12:12 PM | Checkpoint Capital L.P. (Filed by) Pieris Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/14/2024 8:19 AM | Lynx1 Capital Management LP (Filed by) Pieris Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/02/2024 8:59 AM | Pieris Pharmaceuticals (Subject) Soleus Capital Master Fund, L.P. (Filed by)
| Form SC 13G/A | |
12/21/2023 3:30 PM | Pieris Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/14/2023 3:02 PM | Pieris Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/17/2023 3:49 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by) Pieris Pharmaceuticals (Subject)
| Form SC 13D/A | |
07/18/2023 8:15 AM | Pieris Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
07/13/2023 6:30 AM | Pieris Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/26/2023 4:25 PM | Pieris Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/23/2023 3:45 PM | Pieris Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 3:45 PM | Pieris Pharmaceuticals (Issuer) Sherman Matthew L (Reporting) Sherman Matthew L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 3:45 PM | Pieris Pharmaceuticals (Issuer) Pieris Pharmaceuticals (Issuer) Said Maya R. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 3:45 PM | Pieris Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 3:45 PM | Pieris Pharmaceuticals (Issuer) Richman Michael (Reporting) Richman Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 3:46 PM | Pieris Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 3:46 PM | KIRITSY CHRISTOPHER P (Reporting) KIRITSY CHRISTOPHER P (Reporting) Pieris Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 3:46 PM | Kiener Peter A (Reporting) Kiener Peter A (Reporting) Pieris Pharmaceuticals (Issuer) Pieris Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 3:46 PM | Pieris Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 3:46 PM | GERAGHTY JAMES A (Reporting) GERAGHTY JAMES A (Reporting) Pieris Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 3:47 PM | Barbier Ann (Reporting) Pieris Pharmaceuticals (Issuer) Pieris Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/21/2023 6:00 AM | Pieris Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/08/2023 5:01 AM | Pieris Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/30/2023 3:21 PM | KIRITSY CHRISTOPHER P (Reporting) Pieris Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/22/2023 3:47 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by) Pieris Pharmaceuticals (Subject)
| Form SC 13D | |
05/10/2023 6:30 AM | Pieris Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/29/2023 6:30 AM | Pieris Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |